Prescription products require an online evaluation by a licensed medical professional. Clinical services and prescribed medications are provided by US-licensed clinicians from OpenLoop Healthcare Partners P.C. and its affiliated professional entities — independent medical groups with a network of United States-based health care providers. The medical groups determine eligibility based on medical history. To learn more click here.

Medication photos, vials, pills, and any package images on this site are for illustration only; actual packaging may vary depending on the compounding pharmacy that prepares your medication. VivioMD is not a pharmacy or a manufacturer of any medication. Where clinically appropriate, a provider may prescribe a compounded medication, which is prepared by independent, state-licensed compounding pharmacies. Although compounded drugs may lawfully be prescribed under federal law, they are not FDA-approved and do not undergo FDA review for safety, effectiveness, or manufacturing quality.

The trademarks, service marks, trade names, and products referenced on this site (including Wegovy®, Ozempic®, Mounjaro®, and Zepbound®) are the property of their respective owners. VivioMD is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly. Personalized compounded medications available through the VivioMD program are not manufactured by, or under the direction or control of, Novo Nordisk or Eli Lilly. Only Novo Nordisk has FDA-approved products containing semaglutide, under the trade names Wegovy® and Ozempic®. Novo Nordisk does not sell semaglutide to any entities for use in compounding. Ozempic® is not FDA-approved for weight loss. Only Eli Lilly has FDA-approved products containing tirzepatide, under the trade names Mounjaro® and Zepbound®. Eli Lilly does not sell tirzepatide to any entities for use in compounding. Mounjaro® is not FDA-approved for weight loss.